DOI:
10.1055/s-00000105
Zentralblatt für Gynäkologie
LinksClose Window
References
Reichardt P, Minckwitz G, Thuss-Patience PC. et al.
Multicenter phase II study of oral capecitabine (Xeloda) in patients with metastatic breast cancer relapsing after treatment with a taxane-containing therapy.
Ann Oncol 2003; 14: 1227-1233
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.